COVID-19: A Geriatric Emergency

Virginia Boccardi1, Carmelinda Ruggiero1, Patrizia Mecocci1

  • 1Section of Gerontology and Geriatrics, Department of Medicine, University of Perugia, Santa Maria della Misericordia Hospital, 06132 Perugia, Italy.

Insights

Older Italian adults face high COVID-19 mortality due to frailty and multiple health conditions. Early diagnosis and community-based treatment are crucial to prevent intensive care unit overload.

Area of Science:

  • Gerontology
  • Infectious Diseases
  • Public Health

Background:

  • The aging Italian population presents a significant challenge regarding COVID-19 mortality.
  • Pre-existing health conditions, particularly in older adults, are strongly associated with increased COVID-19 fatality risk.

Discussion:

  • Frailty, indicated by multiple comorbidities in older patients, heightens vulnerability to stressors and impairs physiological compensatory mechanisms.
  • Managing frail patients with COVID-19 is clinically complex, increasing complication risks and complicating early symptom recognition.

Key Insights:

  • Frailty exacerbates COVID-19 severity and mortality in the elderly.
  • Atypical symptom presentation in frail older adults necessitates heightened clinical vigilance.
  • Multisystemic frailty impacts the body's ability to maintain homeostasis during infection.

Outlook:

  • Urgent need for interdisciplinary collaboration, sharing geriatric expertise in managing frail COVID-19 patients.
  • Implementing early, community-based diagnosis and treatment is vital to prevent healthcare system collapse, especially intensive care units.

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
137
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
162
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
703
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
130
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
180
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
135